Back to top
more

PetMed Express (PETS)

(Delayed Data from NSDQ)

$3.90 USD

3.90
97,084

+0.04 (1.04%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $3.90 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 22% (54 out of 250)

Industry: Internet - Commerce

Better trading starts here.

Zacks News

Amazon (AMZN) Rules E-Commerce: 3 Contenders to Watch Out

Companies like EVINE Live Inc. (EVLV), PetMed Express, Inc. (PETS) and Wal-Mart Stores Inc. (WMT) are likely to gain from the growing e-commerce market.

    The Zacks Analyst Blog Highlights: CVS Health, Aetna, PetMed Express, Align Technology and Myriad Genetics

    The Zacks Analyst Blog Highlights: CVS Health, Aetna, PetMed Express, Align Technology and Myriad Genetics

      First Data (FDC) Acquires BluePay, Boosts Service Offerings

      First Data Corporation (FDC) acquires BluePay Holdings to expand its offerings in the high-growth integrated payments space.

        Ecolab Focuses on Pest Elimination, Acquires 3 Companies

        Ecolab (ECL) continues to focus on investment in key growth businesses and bolt-on acquisitions to gain market traction and boost profits and inorganic growth.

          Quest Diagnostics Banks on Buyouts to Expand in Diagnostic

          Quest Diagnostics (DGX) actively pursues merger and acquisitions to solidify hold in the high-potential diagnostic information services market. Notably, Cleveland HeartLab buyout marks as the latest deal.

            Patterson Companies-SprintRay Deal to Boost Dental Unit

            Patterson Companies (PDCO) focuses on acquisitions to boost dental segment.

              CVS Health's Aetna Buyout to Change Healthcare Landscape

              Once the Aetna deal is through, CVS Health (CVS) expects to draw $750 million from near-term synergies with low to mid-single digit accretion in the second year.

                Cooper Companies' (COO) CooperVision Buys Paragon for $80M

                The Cooper Companies (COO) focuses on strategic acquisitions to drive inorganic growth.

                  Boston Scientific (BSX) Shares Drop on LOTUS Relaunch Delay

                  Boston Scientific (BSX) announces a delay in deadline for the commercial return of the LOTUS Edge Aortic Valve System in Europe. Following this news, share price declines.

                    BioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo

                    BioTelemetry (BEAT) progresses with deals to strengthen hold in the high-potential diabetes care market.

                      ResMed (RMD) Rides on Innovation Amid Reimbursement Woes

                      ResMed (RMD) achieves strong global revenue growth for the past few quarters on the back of sales of sleep devices, respiratory care devices, mask systems and software solutions.

                        Here's Why You Should Add Chemed (CHE) to Your Portfolio Now

                        Chemed (CHE) continues to ride high on strength in Roto-Rooter business.

                          Bio-Rad (BIO) at a 52-Week High: What's Driving the Stock?

                          Bio-Rad (BIO) consistently invests in R&D for product innovation.

                            BioTelemetry Ties Up With Apple, Grows in Cardiac Monitoring

                            BioTelemetry (BEAT) is consistently trying to improve its position in the cardiac monitoring and diagnostic services space.

                              Flexion's (FLXN) Zilretta Therapy to Fast Capture OA Market

                              Flexion's (FLXN) commercial launch of Zilretta seems well-timed keeping in view how rapidly the osteoarthritis market is growing worldwide.

                                Veeva Systems (VEEV) Grows in Digital Asset Management Space

                                Veeva Systems' (VEEV) constant endeavors seem to boost the Veeva Vault portfolio.

                                  Amazon (AMZN) Witnesses Biggest Cyber Monday Bonanza Ever

                                  Cyber Monday becomes single biggest shopping day ever for Amazon.com Inc. (AMZN).

                                    Here's Why You Should Invest in Baxter (BAX) Stock Right Now

                                    Baxter has witnessed favorable tidings on the regulatory front. The company enjoys strong presence in foreign markets.

                                      Varian's Partners Penn Medicine, Proton Therapy in Focus

                                      Varian Medical's (VAR) solid prospects on the proton therapy space holds promise at the moment.

                                        Genomic Health-Cleveland Diagnostics Deal to Boost Test Suite

                                        Genomic Health (GHDX) forges ahead with deals to strengthen hold in the high-potential prostate cancer therapeutics market.

                                          GNC Holdings Grapples With Margin Weakness, Stiff Competition

                                          Weak margins, declining year-over-year revenues and rising operating costs continue to pose challenges to GNC Holdings (GNC).

                                            Stryker Gains Ground on MAKO Robotic Unit Amid Forex Woes

                                            Solid performance by the MAKO robotic platform has been boosting Stryker's (SYK) revenues for long.

                                              LabCorp's Covance Business Bounces Back on Chiltern Buyout

                                              Despite a dull show for several quarters, LabCorp's (LH) Covance Drug Development reported strong growth in the third quarter, courtesy of Chiltern acquisition. However, volume woes remain.

                                                Align Technology (ALGN) Grows on InvisAlign System Strength

                                                Align Technology (ALGN) continues to gain from strength in the InvisAlign space.

                                                  Edwards Lifesciences' Pipeline Strong Amid Rising Expenses

                                                  Edwards Lifesciences' (EW) aim at building its pipeline to fortify foothold across all operating businesses augurs well for the company. However, higher operating expenses are a concern.